Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S., Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 4 - 12 [Scientific article]
Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M., Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2011, 11(6), pp. 462 - 466 [Scientific article]
Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti E.; Derenzini E.; Pileri S.; Baccarani M., Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified., «LEUKEMIA & LYMPHOMA», 2011, 52, pp. 1585 - 1588 [Scientific article]
Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Quirini F; Baccarani M., Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma., «CANCER», 2011, 117, pp. 1010 - 1018 [Scientific article]
Pellegrini C; Gandolfi L; Quirini F; Ruggieri P; Stefoni V; Derenzini E; Broccoli A; Argnani L; Pileri S; Mercuri M; Baccarani M; Zinzani PL., Primary Bone Lymphoma: Evaluation odf Chemoimmunotherapy as Front-line Treatment in 21 Patients, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2011, 11, pp. 321 - 325 [Scientific article]
Agostinelli C.; Gallamini A.; Rigacci L.; Vitolo U.; Stracqualursi L.; Piccaluga P.; Stelitano C.; Patti C.; Argnani. L.; Broccoli A.; Levis A.; D’Amore F.; Zinzani P.; Pileri S.A., The prognostic value of biologic markers in classical hodgkin lymphoma (CHL) patients., in: 11th International Conference onMalignant Lymphoma,15 - 18 June, 2011,Lugano, Switzerland, «ANNALS OF ONCOLOGY», 2011, 22(suppl4), pp. 206 - 206 (atti di: 11th International Conference on Malignant Lymphoma., Lugano, Switzerland, 15 - 18 June, 2011.) [Abstract]
Zinzani PL; Venturini F; Stefoni V; Fina M; Pellegrini C; Derenzini E;
Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M., Gemcitabine
as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome., «ANNALS OF ONCOLOGY», 2010, 21, pp. 860 - 863 [Scientific article]
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M., Hairy cell leukemia: evaluation of the long-term outcome in 121 patients., «CANCER», 2010, 116, pp. 4788 - 4792 [Scientific article]
Zinzani PL; Broccoli A; Stefoni V; Musuraca G; Abruzzese E; De Renzo A; Cantonetti M; Bacci F; Baccarani M; Pileri SA., Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients., «CANCER», 2010, 116, pp. 5667 - 5675 [Scientific article]
Luigi Zinzani, Pier; Argnani, Lisa; Broccoli, Alessandro, Local versus systemic treatment for primary cutaneous B-Cell lymphoma, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2010, 10, pp. S103 - S105 [Scientific article]
Derenzini E; Fina MP; Stefoni V; Pellegrini C; Venturini F; Broccoli A; Gandolfi L; Pileri S; Fanti S; Lopci E; Castellucci P; Agostinelli C; Baccarani M; Zinzani PL., MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients., «ANNALS OF ONCOLOGY», 2010, 21, pp. 1173 - 1178 [Scientific article]
Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M., Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients., «CLINICAL CANCER RESEARCH», 2010, 16(15), pp. 3998 - 4004 [Scientific article]
Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M., Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2010, 10(4), pp. 258 - 261 [Scientific article]
Stefoni V; Broccoli A; Pellegrini C; Derenzini E; Fina M; Zinzani PL., CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission., «JOURNAL OF NEURO-ONCOLOGY», 2009, 95(1), pp. 135 - 139 [Scientific article]
Derenzini E; Stefoni V; Pellegrini C; Fina MP; Broccoli A; Venturini F;
Gandolfi L; Pileri SA; Martelli M; Petti MC; Perrotti A; De Renzo A; Zaja F;Baccarani M; Zinzani PL., Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma., «LEUKEMIA & LYMPHOMA», 2009, 50(11), pp. 1824 - 1829 [Scientific article]
